InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Krause Kevin Michael. Director active across 1 company, notably AN2 Therapeutics, Inc.. In total, 4 filings have been published. History available since 2 January 2024. The latest transaction was filed on 15 March 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Kevin Michael Krause is a declarant linked to AN2 Therapeutics, Inc., where he serves as Chief Strategy Officer. He has 4 filings in total, and the recent filings we hold run from 2024-01-04 to 2024-03-29, with the modal transaction nature indicated as Attribution.